These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19834547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
    Yamashita H, Nakagawa K, Tago M, Igaki H, Nakamura N, Shiraishi K, Sasano N, Ohtomo K.
    Dis Esophagus; 2006; 19(1):15-9. PubMed ID: 16364038
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
    Kuwahara A, Yamamori M, Kadoyama K, Nishiguchi K, Nakamura T, Miki I, Tamura T, Okuno T, Omatsu H, Sakaeda T.
    J Exp Clin Cancer Res; 2011 Oct 05; 30(1):94. PubMed ID: 21970688
    [Abstract] [Full Text] [Related]

  • 5. VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
    Tamura T, Kuwahara A, Yamamori M, Nishiguchi K, Nakamura T, Okuno T, Miki I, Manabe Y, Sakaeda T.
    Int J Med Sci; 2012 Oct 05; 9(10):833-7. PubMed ID: 23155356
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N, Morimoto J, Tanaka H, Ohira M, Noda E, Amano R, Inoue T, Yamada N, Yashiro M, Maeda K, Yamashita Y, Muguruma K, Sawada T, Hirakawa K.
    Gan To Kagaku Ryoho; 2009 Nov 05; 36(12):1997-9. PubMed ID: 20037303
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H, Haga A, Takenaka R, Kiritoshi T, Okuma K, Ohtomo K, Nakagawa K.
    Radiat Oncol; 2016 Jan 19; 11():4. PubMed ID: 26781439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T, Nakamura K, Toba T, Kimura M, Ohga S, Urashima Y, Terashima H, Masuda K.
    Gan To Kagaku Ryoho; 2002 Aug 19; 29(8):1417-20. PubMed ID: 12214470
    [Abstract] [Full Text] [Related]

  • 11. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
    Takeda Y, Kasai H, Uchida N, Yoshida H, Maekawa R, Sugita K, Yoshioka T.
    Anticancer Res; 1999 Aug 19; 19(5B):4059-64. PubMed ID: 10628354
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M.
    Jpn J Clin Oncol; 2004 Oct 19; 34(10):615-9. PubMed ID: 15591460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K.
    Jpn J Clin Oncol; 2009 Jan 19; 39(1):37-42. PubMed ID: 19103671
    [Abstract] [Full Text] [Related]

  • 15. Phase I trial of escalating-dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer.
    Lin Q, Gao XS, Qiao XY, Zhou ZG, Zhang P, Chen K, Zhao YN, Asaumi J.
    Acta Med Okayama; 2008 Feb 19; 62(1):37-44. PubMed ID: 18323870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P, Feng FY, Wu LY, Hu Y, Liu JW, Gao YJ, Guan XQ, Nan KJ, Suo AL, Wang XW, Zhang MH, Zhang WD, Li CW, Zhang Y, Zhao JB.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 19; 28(3):230-4. PubMed ID: 16875614
    [Abstract] [Full Text] [Related]

  • 18. [A case of local advanced cervical esophageal cancer treated with concurrent radiochemotherapy followed by surgery].
    Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Takakita S, Kusumi F, Kato Y, Takeda H.
    Gan To Kagaku Ryoho; 1997 Oct 19; 24(13):2001-4. PubMed ID: 9350249
    [Abstract] [Full Text] [Related]

  • 19. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A, Yamagishi H, Itoi H, Fujiwara H, Kikuchi S, Okamoto K, Ichikawa D, Fuji N, Ochiai T, Sonoyama T, Ueda Y.
    Oncol Rep; 2005 Apr 19; 13(4):667-72. PubMed ID: 15756440
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.